Leadership Team

The Leadership Team at Sonnet BioTherapeutics is responsible for setting the strategic direction and vision of the company, guiding the development of innovative biologic drugs leveraging the FHAB™ technology. Comprising key executives from finance, science, medical, and technical backgrounds, the team collaborates to drive research initiatives, oversee clinical development, ensure regulatory compliance, and foster partnerships to enhance the company's market position and therapeutic impact.